Market Insights Health Medical Technology Medical Devices

Endoscopic Devices - China

China

Revenue in the Endoscopic Devices market market in China is anticipated to attain US$1.92bn in 2024.
This revenue is forecasted to exhibit an annual growth rate (CAGR 2024-2029) of 8.60%, leading to a market volume of US$2.90bn by 2029.
In a global context, the majority of revenue is projected to be generated the United States with a figure of US$10,390.00m in 2024.
China's burgeoning healthcare sector is increasingly adopting advanced endoscopic devices, driven by rising patient demand and an emphasis on minimally invasive surgical techniques.

Key regions: Italy, United Kingdom, Netherlands, Germany, Japan

Market

Region

Region comparison

Currency

Analyst Opinion

The Endoscopic Devices Market within the Medical Devices sector in China is experiencing moderate growth, influenced by factors such as technological advancements, increasing demand for minimally invasive surgeries, and a growing aging population seeking effective healthcare solutions.

Customer preferences: Consumers in China are increasingly prioritizing advanced healthcare solutions that offer minimally invasive procedures, reflecting a cultural shift towards valuing efficiency and recovery speed. This trend is further fueled by the aging population, which seeks less traumatic surgical options with quicker recovery times. Additionally, heightened health awareness and a growing preference for personalized medical experiences are driving demand for innovative endoscopic devices, enabling tailored treatments that align with individual health needs and lifestyles.

Trends in the market: In China, the Endoscopic Devices Market is experiencing a significant shift towards advanced minimally invasive surgical solutions, driven by an aging population that favors quicker recovery and reduced trauma. This trend is accompanied by rising health awareness and a demand for personalized medical experiences, leading to increased adoption of innovative endoscopic technologies. Industry stakeholders are recognizing the importance of investing in research and development to create tailored devices that meet the specific health needs of patients, ultimately enhancing patient outcomes and expanding market share in a competitive landscape.

Local special circumstances: In China, the Endoscopic Devices Market is shaped by unique local factors, including a vast population and regional disparities in healthcare access. Urban areas are prioritizing advanced minimally invasive technologies, while rural regions face challenges in accessing such innovations. Cultural preferences for traditional medicine also influence patient acceptance of endoscopic procedures. Additionally, stringent regulatory frameworks promote high safety standards, encouraging local manufacturers to innovate. These elements collectively drive the demand for customized endoscopic solutions that address the diverse needs of China's population, positioning the market for robust growth.

Underlying macroeconomic factors: The Endoscopic Devices Market in China is significantly influenced by macroeconomic factors including national economic growth, healthcare funding, and demographic shifts. The country’s robust GDP growth supports increased healthcare expenditure, leading to greater investment in advanced medical technologies. Additionally, government fiscal policies aimed at expanding healthcare access and improving infrastructure are driving market expansion. The rising prevalence of lifestyle-related diseases necessitates innovative endoscopic solutions, while a growing aging population further fuels demand. Furthermore, global economic trends and trade dynamics impact the availability and pricing of endoscopic devices, shaping competitive strategies among local and international manufacturers.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.